The ABC Of ADC Manufacturing: Navigating 5 Overlooked Challenges In Bioconjugate Manufacturing

Antibody-drug conjugates (ADCs) hold immense promise in the fight against cancer, but their production is a complex puzzle with many pieces. From the tricky process of linking potent drugs to antibodies to the challenges of maintaining stability and scaling up production, ADC manufacturing is a delicate balancing act. This article unveils the hidden complexities behind these life-saving treatments, exploring the critical role of bioconjugation, the importance of safety, and the quest for efficient, scalable production.

Discover how innovative technologies are transforming this field and paving the way for a future where ADCs become a cornerstone of cancer therapy.